Artemisinin alleviates obesity‐related glomerulopathy by downregulating CYP24A1 expression

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 26; no. 2; pp. 767 - 771
Main Authors Chen, Xiaorong, Xiang, Jie, Gao, Peng, Wang, Lijuan, Xiang, Li, Lu, Zongshi, Cao, Tingbing, Mou, Aidi, Zhang, Xingping, Jiang, Xiaoyan, Zhu, Zhiming, Lang, Hongmei
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2024
Wiley Subscription Services, Inc
Subjects
Antiparasitic agents
Artemisinin
Artemisinins - metabolism
CYP24A1
Gene expression
Humans
inflammation
Kidney diseases
Obesity
Obesity - complications
Obesity - drug therapy
Obesity - metabolism
obesity‐related glomerulopathy
podocyte injury
Podocytes - metabolism
vitamin D
Vitamin D - metabolism
Vitamin D3 24-Hydroxylase - metabolism
artemisinin
CYP24A1
inflammation
podocyte injury
obesity-related glomerulopathy
vitamin D
Online AccessGet full text

Cover

More Information
Bibliography:Hongmei Lang is the lead contact.
Xiaorong Chen and Jie Xiang should be considered joint first authors.
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.15355